Comparison of Medication Adherence and Healthcare Costs between Duloxetine and Pregabalin Initiators among Patients with Fibromyalgia (Q84970272)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20807351%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

title

Comparison of medication adherence and healthcare costs between duloxetine and pregabalin initiators among patients with fibromyalgia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20807351%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Comparison of Medication Adherence and Healthcare Costs between Duloxetine and Pregabalin Initiators among Patients with Fibromyalgia (English)

1 reference

https://api.crossref.org/works/10.1111/J.1533-2500.2010.00412.X

4 July 2024

1 reference

Yang Zhao

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20807351%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Peter Sun

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20807351%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Peter Watson

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20807351%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Beth Mitchell

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20807351%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Ralph Swindle

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20807351%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20807351

4 July 2024

publication date

27 August 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20807351%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

13 February 2020

https://doi.org/10.1111/j.1533-2500.2010.00412.x

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20807351

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1533-2500.2010.00412.x

4 July 2024

1 reference

https://api.crossref.org/works/10.1111/J.1533-2500.2010.00412.X

https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1533-2500.2010.00412.x

4 July 2024

1 reference

https://api.crossref.org/works/10.1111/J.1533-2500.2010.00412.X

4 July 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20807351%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

volume

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20807351%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20807351%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

page(s)

204-216

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20807351%20AND%20SRC:MED&resulttype=core&format=json

The prevalence of fibromyalgia in women aged 20-64 in Turkey

13 February 2020

cites work

2

1 reference

https://api.crossref.org/works/10.1111/J.1533-2500.2010.00412.X

The incidence of fibromyalgia and its associated comorbidities: a population-based retrospective cohort study based on International Classification of Diseases, 9th Revision codes

4 July 2024

3

1 reference

https://api.crossref.org/works/10.1111/J.1533-2500.2010.00412.X

The prevalence of fibromyalgia in Japanese workers.

4 July 2024

4

1 reference

https://api.crossref.org/works/10.1111/J.1533-2500.2010.00412.X

The assessment of functional impairment in fibromyalgia (FM): Rasch analyses of 5 functional scales and the development of the FM Health Assessment Questionnaire

4 July 2024

9

1 reference

https://api.crossref.org/works/10.1111/J.1533-2500.2010.00412.X

The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee

4 July 2024

10

1 reference

https://api.crossref.org/works/10.1111/J.1533-2500.2010.00412.X

Prevalence of fibromyalgia: a survey in five European countries

4 July 2024

11

1 reference

https://api.crossref.org/works/10.1111/J.1533-2500.2010.00412.X

Fibromyalgia syndrome in the general population of France: a prevalence study

4 July 2024

12

1 reference

https://api.crossref.org/works/10.1111/J.1533-2500.2010.00412.X

Elements of fibromyalgia in an open population

4 July 2024

13

1 reference

https://api.crossref.org/works/10.1111/J.1533-2500.2010.00412.X

[Epidemiological study of a primary fibromyalgia in pediatric age]

4 July 2024

16

1 reference

https://api.crossref.org/works/10.1111/J.1533-2500.2010.00412.X

The prevalence and characteristics of fibromyalgia in the general population.

4 July 2024

17

1 reference

https://api.crossref.org/works/10.1111/J.1533-2500.2010.00412.X

Work disability and health system utilization in patients with fibromyalgia syndrome

4 July 2024

19

1 reference

https://api.crossref.org/works/10.1111/J.1533-2500.2010.00412.X

In search of pharmacoeconomic evaluations for fibromyalgia treatments: a review

4 July 2024

20

1 reference

https://api.crossref.org/works/10.1111/J.1533-2500.2010.00412.X

An internet survey of 2,596 people with fibromyalgia

4 July 2024

21

1 reference

https://api.crossref.org/works/10.1111/J.1533-2500.2010.00412.X

Women's health issues with fibromyalgia syndrome

4 July 2024

22

1 reference

https://api.crossref.org/works/10.1111/J.1533-2500.2010.00412.X

Predicting high physical function in people with fibromyalgia

4 July 2024

23

1 reference

https://api.crossref.org/works/10.1111/J.1533-2500.2010.00412.X

Characteristics and healthcare costs of patients with fibromyalgia syndrome

4 July 2024

24

1 reference

https://api.crossref.org/works/10.1111/J.1533-2500.2010.00412.X

A comparison of physical functional performance and strength in women with fibromyalgia, age- and weight-matched controls, and older women who are healthy

4 July 2024

25

1 reference

https://api.crossref.org/works/10.1111/J.1533-2500.2010.00412.X

Disability and quality of life in patients with fibromyalgia

4 July 2024

26

1 reference

https://api.crossref.org/works/10.1111/J.1533-2500.2010.00412.X

Quality of life, functional disability and lifestyle among subgroups of fibromyalgia patients: the significance of anxiety and depression

4 July 2024

27

1 reference

https://api.crossref.org/works/10.1111/J.1533-2500.2010.00412.X

Employees with fibromyalgia: medical comorbidity, healthcare costs, and work loss

4 July 2024

28

1 reference

https://api.crossref.org/works/10.1111/J.1533-2500.2010.00412.X

EULAR evidence-based recommendations for the management of fibromyalgia syndrome

4 July 2024

29

1 reference

https://api.crossref.org/works/10.1111/J.1533-2500.2010.00412.X

Fibromyalgia. Diagnosis and management

4 July 2024

30

1 reference

https://api.crossref.org/works/10.1111/J.1533-2500.2010.00412.X

Fibromyalgia: presentation and management with a focus on pharmacological treatment

4 July 2024

31

1 reference

https://api.crossref.org/works/10.1111/J.1533-2500.2010.00412.X

Guidelines on the management of fibromyalgia syndrome - a systematic review

4 July 2024

33

1 reference

https://api.crossref.org/works/10.1111/J.1533-2500.2010.00412.X

Management of fibromyalgia: what are the best treatment choices?

4 July 2024

34

1 reference

https://api.crossref.org/works/10.1111/J.1533-2500.2010.00412.X

Ottawa Panel evidence-based clinical practice guidelines for aerobic fitness exercises in the management of fibromyalgia: part 1.

4 July 2024

35

1 reference

https://api.crossref.org/works/10.1111/J.1533-2500.2010.00412.X

Ottawa Panel evidence-based clinical practice guidelines for strengthening exercises in the management of fibromyalgia: part 2.

4 July 2024

36

1 reference

https://api.crossref.org/works/10.1111/J.1533-2500.2010.00412.X

Pain management in fibromyalgia

4 July 2024

37

1 reference

https://api.crossref.org/works/10.1111/J.1533-2500.2010.00412.X

Effectiveness of the psychological and pharmacological treatment of catastrophization in patients with fibromyalgia: a randomized controlled trial.

4 July 2024

38

1 reference

https://api.crossref.org/works/10.1111/J.1533-2500.2010.00412.X

Efficacy and safety of duloxetine for treatment of fibromyalgia in patients with or without major depressive disorder: Results from a 6-month, randomized, double-blind, placebo-controlled, fixed-dose trial

4 July 2024

39

1 reference

https://api.crossref.org/works/10.1111/J.1533-2500.2010.00412.X

A randomized, double-blind, placebo-controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorder

4 July 2024

40

1 reference

https://api.crossref.org/works/10.1111/J.1533-2500.2010.00412.X

A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder

4 July 2024

41

1 reference

https://api.crossref.org/works/10.1111/J.1533-2500.2010.00412.X

Pregabalin for the treatment of fibromyalgia syndrome: results of a randomized, double-blind, placebo-controlled trial

4 July 2024

42

1 reference

https://api.crossref.org/works/10.1111/J.1533-2500.2010.00412.X

Pregabalin augmentation of quetiapine therapy in the treatment of fibromyalgia: an open-label, prospective trial.

4 July 2024

43

1 reference

https://api.crossref.org/works/10.1111/J.1533-2500.2010.00412.X

Fibromyalgia relapse evaluation and efficacy for durability of meaningful relief (FREEDOM): a 6-month, double-blind, placebo-controlled trial with pregabalin

4 July 2024

44

1 reference

https://api.crossref.org/works/10.1111/J.1533-2500.2010.00412.X

Milnacipran for the treatment of fibromyalgia in adults: a 15-week, multicenter, randomized, double-blind, placebo-controlled, multiple-dose clinical trial

4 July 2024

46

1 reference

https://api.crossref.org/works/10.1111/J.1533-2500.2010.00412.X

A double-blind placebo-controlled trial of milnacipran in the treatment of fibromyalgia

4 July 2024

48

1 reference

https://api.crossref.org/works/10.1111/J.1533-2500.2010.00412.X

Medication compliance and persistence: terminology and definitions

4 July 2024

49

1 reference

https://api.crossref.org/works/10.1111/J.1533-2500.2010.00412.X

Methods to measure patient compliance with medication regimens

4 July 2024

50

1 reference

https://api.crossref.org/works/10.1111/J.1533-2500.2010.00412.X

A checklist for medication compliance and persistence studies using retrospective databases.

4 July 2024

51

1 reference

https://api.crossref.org/works/10.1111/J.1533-2500.2010.00412.X

The effectiveness of insulin initiation regimens in patients with type 2 diabetes mellitus: a large national medical records review study comparing a basal insulin analogue to premixed insulin

4 July 2024

52

1 reference

https://api.crossref.org/works/10.1111/J.1533-2500.2010.00412.X

Firearm violence exposure and serious violent behavior

4 July 2024

53

1 reference

https://api.crossref.org/works/10.1111/J.1533-2500.2010.00412.X

Stratification and weighting via the propensity score in estimation of causal treatment effects: a comparative study

4 July 2024

54

1 reference

https://api.crossref.org/works/10.1111/J.1533-2500.2010.00412.X

The central role of the propensity score in observational studies for causal effects

4 July 2024

56

1 reference

https://api.crossref.org/works/10.1111/J.1533-2500.2010.00412.X

Estimating causal effects from large data sets using propensity scores

4 July 2024

57

1 reference

https://api.crossref.org/works/10.1111/J.1533-2500.2010.00412.X

The design versus the analysis of observational studies for causal effects: parallels with the design of randomized trials

4 July 2024

58

1 reference

https://api.crossref.org/works/10.1111/J.1533-2500.2010.00412.X

On principles for modeling propensity scores in medical research

4 July 2024

59

1 reference

https://api.crossref.org/works/10.1111/J.1533-2500.2010.00412.X

A general population study of fibromyalgia tender points in noninstitutionalized adults with chronic widespread pain

4 July 2024

60

1 reference

https://api.crossref.org/works/10.1111/J.1533-2500.2010.00412.X

The London Fibromyalgia Epidemiology Study: direct health care costs of fibromyalgia syndrome in London, Canada

4 July 2024

61

1 reference

https://api.crossref.org/works/10.1111/J.1533-2500.2010.00412.X

Health economic consequences related to the diagnosis of fibromyalgia syndrome

4 July 2024

62

1 reference

https://api.crossref.org/works/10.1111/J.1533-2500.2010.00412.X

The economic burden of depression with painful symptoms

4 July 2024

63

1 reference

https://api.crossref.org/works/10.1111/J.1533-2500.2010.00412.X

Treatment of fibromyalgia syndrome with antidepressants: a meta-analysis

4 July 2024

64

1 reference

https://api.crossref.org/works/10.1111/J.1533-2500.2010.00412.X

Opioid-induced bowel dysfunction in cancer-related pain: causes, consequences, and a novel approach for its management

4 July 2024

66

1 reference

https://api.crossref.org/works/10.1111/J.1533-2500.2010.00412.X

NSAID use in individuals at risk of renal adverse events: an observational study to investigate trends in Australian veterans

4 July 2024

68

1 reference

https://api.crossref.org/works/10.1111/J.1533-2500.2010.00412.X

NSAID use increases the risk of developing hyponatremia during an Ironman triathlon.

4 July 2024

70

1 reference

https://api.crossref.org/works/10.1111/J.1533-2500.2010.00412.X

NSAID-analgesia, pain control and morbidity in cardiothoracic surgery

4 July 2024

71

1 reference

https://api.crossref.org/works/10.1111/J.1533-2500.2010.00412.X

A review of NSAID complications: gastrointestinal and more

4 July 2024

72

1 reference

https://api.crossref.org/works/10.1111/J.1533-2500.2010.00412.X

4 July 2024

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20807351%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

1 reference